FDA Approves Immunotherapy Treatment for Adult Respiratory Papillomatosis

Final reports from Precigen showed long-term effectiveness of the injections with reduced side effects. The Food and Drug Administration (FDA) has approved a drug manufactured by Precigen to…

Read More

HHS Secretary Pulls $500 Million from mRNA Vaccine Research

Biomedical research will continue with a focus on whole-virus vaccines and novel platforms. U.S. Health Secretary Robert F. Kennedy, Jr. revoked $500 million in mRNA vaccine development contracts…

Read More

Back to top
FE3